The relationship between the expression levels of HSPA6 or HMOX1 genes and prognosis of myeloma patients treated with proteasome inhibitors was assessed using gene expression data and clinical information obtained from the public database (GSE9782) [22]. This evidence concerns the gene HMOX1 and plasma cell myeloma.